Cabré A - Search Results

1

APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome.

Castro A, Lázaro I, Selva DM, Céspedes E, Girona J, NúriaPlana, Guardiola M, Cabré A, Simó R, Masana L. Castro A, et al. Among authors: cabre a. Atherosclerosis. 2010 Mar;209(1):201-5. doi: 10.1016/j.atherosclerosis.2009.09.072. Epub 2009 Oct 6. Atherosclerosis. 2010. PMID: 19878946

2

Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.

Girona J, Manzanares JM, Marimón F, Cabré A, Heras M, Guardiola M, Ribalta J, Masana L. Girona J, et al. Among authors: cabre a. Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):380-7. doi: 10.1016/j.numecd.2007.04.002. Epub 2007 Sep 29. Nutr Metab Cardiovasc Dis. 2008. PMID: 17904830

3

The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients.

Coll B, Cabre A, Alonso-Villaverde C, Lazaro I, Aragonés G, Parra S, Girona J, Masana L. Coll B, et al. Among authors: cabre a. Atherosclerosis. 2008 Jul;199(1):147-53. doi: 10.1016/j.atherosclerosis.2007.09.032. Epub 2007 Nov 5. Atherosclerosis. 2008. PMID: 17983623

4

Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria.

Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F, Plana N, Heras M, Masana L. Cabré A, et al. Clin Chem. 2008 Jan;54(1):181-7. doi: 10.1373/clinchem.2007.094672. Epub 2007 Nov 16. Clin Chem. 2008. PMID: 18024526

5

The apolipoprotein A5 gene -1131T-->C polymorphism affects vitamin E plasma concentrations in type 2 diabetic patients.

Girona J, Guardiola M, Cabré A, Manzanares JM, Heras M, Ribalta J, Masana L. Girona J, et al. Among authors: cabre a. Clin Chem Lab Med. 2008;46(4):453-7. doi: 10.1515/CCLM.2008.110. Clin Chem Lab Med. 2008. PMID: 18302531

6

Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes.

Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F, Plana N, Heras M, Masana L. Cabré A, et al. J Lipid Res. 2008 Aug;49(8):1746-51. doi: 10.1194/jlr.M800102-JLR200. Epub 2008 Apr 17. J Lipid Res. 2008. PMID: 18421072 Free article.

7

Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes.

Aragonès G, Ferré R, Lázaro I, Cabré A, Plana N, Merino J, Heras M, Girona J, Masana L. Aragonès G, et al. Among authors: cabre a. Atherosclerosis. 2010 Nov;213(1):329-31. doi: 10.1016/j.atherosclerosis.2010.07.026. Epub 2010 Jul 27. Atherosclerosis. 2010. PMID: 20723896

8

FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study.

Cabré A, Babio N, Lázaro I, Bulló M, Garcia-Arellano A, Masana L, Salas-Salvadó J. Cabré A, et al. Atherosclerosis. 2012 May;222(1):229-34. doi: 10.1016/j.atherosclerosis.2012.02.003. Epub 2012 Feb 24. Atherosclerosis. 2012. PMID: 22420890 Clinical Trial.

9

Akt and ERK/Nrf2 activation by PUFA oxidation-derived aldehydes upregulates FABP4 expression in human macrophages.

Lázaro I, Ferré R, Masana L, Cabré A. Lázaro I, et al. Among authors: cabre a. Atherosclerosis. 2013 Oct;230(2):216-22. doi: 10.1016/j.atherosclerosis.2013.07.043. Epub 2013 Aug 1. Atherosclerosis. 2013. PMID: 24075747

10

Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients.

Cabré A, Lázaro I, Girona J, Manzanares JM, Marimón F, Plana N, Heras M, Masana L. Cabré A, et al. Atherosclerosis. 2007 Nov;195(1):e150-8. doi: 10.1016/j.atherosclerosis.2007.04.045. Epub 2007 Jun 5. Atherosclerosis. 2007. PMID: 17553506

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters